EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Role of Thrombectomy Technique in Alteplase Bridging Intravenous Thrombolysis for Basilar Artery Occlusion

Muhammad Jaffar iD, Kazi Ahmed iD, Samir Abu-Rumeileh, Markus Otto iD, Lorenzo Barba iD, Thanh N Nguyen iD, Mohamad Abdalkader iD, Piers Klein iD, Kyriakos Lobotesis iD, Mariarosaria Valente iD, Gian Luigi Gigli iD, Soumik Talukder iD und 7 weitere

Journal of the American Heart Association · 2026

DOI: 10.1161/jaha.125.047678 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2026. Verfasst von Muhammad Jaffar und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stroke and Neuroscience Charing Cross Hospital, Imperial College London NHS Healthcare Trust London UK. Hauptthemen laut MEDLINE: Thrombectomy, Fibrinolytic Agents, Thrombolytic Therapy, Tissue Plasminogen Activator. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Endovascular treatment (EVT) is the standard of care for acute basilar artery occlusion (BAO) although the role of bridging intravenous thrombolysis (IVT) with alteplase prior to EVT remains debated. Whether the effect of bridging IVT differs across EVT techniques has not been systematically assessed.

Methods

We conducted a retrospective multicenter analysis including consecutive patients with BAO treated with EVT at 7 comprehensive stroke centers between 2019 and 2023. Patients were stratified according to first‐line thrombectomy technique: direct thromboaspiration (BAO TA ), stent retriever (BAO ST ), or combined approach (BAO CO ). Outcomes were analyzed using inverse probability weighting to adjust for baseline imbalances. The primary end point was 90‐day favorable functional outcome (modified Rankin Scale 0–3) and ordinal 90‐day modified Rankin Scale shift. Secondary end points included 90‐day functional independence (modified Rankin Scale 0–2), successful reperfusion, 90‐day mortality, hemorrhagic transformation, and symptomatic intracerebral hemorrhage. Sensitivity analyses with trimmed weights and subgroup analyses were prespecified.

Results

A total of 517 patients were included: 200 BAO TA , 260 BAO ST, and 57 BAO CO . In patients with BAO TA , bridging IVT was associated with higher rates of 90‐day favorable outcome (risk ratio [RR] 1.47, 95% CI 1.00–2.16) and improved 90‐day modified Rankin Scale shift. In patients with BAO ST bridging IVT significantly reduced symptomatic intracerebral hemorrhage risk (RR 0.27, 95% CI 0.09–0.77) while in patients with BAO CO functional independence was numerically more frequent among patients treated with bridging IVT (RR 1.91, 95% CI 1.08–3.37).

Conclusions

Bridging IVT was associated with differences in clinical and safety outcomes across EVT strategies. However, no statistically significant interaction was observed between treatment allocation and EVT technique. Therefore, these findings should be interpreted as descriptive and hypothesis‐generating rather than evidence of true differences in treatment effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThrombectomyFibrinolytic AgentsThrombolytic TherapyTissue Plasminogen ActivatorVertebrobasilar InsufficiencyEndovascular ProceduresBasilar ArteryHumansRetrospective StudiesBridge TherapyFemaleMaleTreatment OutcomeAgedMiddle Aged

Stichwörter der Autor:innen

aspirationbasilar artery occlusioncombined approachstent retriever

Substanzen

Fibrinolytic AgentsTissue Plasminogen Activator

Autor:innen und Institutionen

  • Department of Stroke and Neuroscience Charing Cross Hospital, Imperial College London NHS Healthcare Trust London UK.
  • Department of Neurology Martin-Luther-University Halle-Wittenberg Halle (Saale) Germany.
  • Department of Neurology Radiology, Boston Medical Center Boston MA USA.
  • Neuroradiology, Department of Imaging Charing Cross Hospital, Imperial College London, NHS Healthcare Trust London UK.
  • Clinical Neurology, Department of Medicine (DAME), Udine University Hospital University of Udine Udine Italy.
  • Clinical Unit of Neurology, Department of Medicine Surgery and Health Sciences, University Hospital and Health Services of Trieste, ASUGI, University of Trieste Trieste Italy.

ORCID-Profile: Muhammad Jaffar, Kazi Ahmed, Markus Otto, Lorenzo Barba, Thanh N Nguyen, Mohamad Abdalkader, Piers Klein, Kyriakos Lobotesis, Mariarosaria Valente, Gian Luigi Gigli, Soumik Talukder, Gabriele Prandin, Liqun Zhang, Matteo Foschi, Giovanni Merlino, Robert Simister, Soma Banerjee, Lucio D'Anna

Zitieren

APA

Jaffar, M., Ahmed, K., Abu-Rumeileh, S., Otto, M., Barba, L., Nguyen, T. N., Abdalkader, M., Klein, P., Lobotesis, K., Valente, M., Gigli, G. L., Talukder, S., Prandin, G., Zhang, L., Foschi, M., Merlino, G., Simister, R., Banerjee, S., & D'Anna, L. (2026). Role of Thrombectomy Technique in Alteplase Bridging Intravenous Thrombolysis for Basilar Artery Occlusion. Journal of the American Heart Association. https://doi.org/10.1161/jaha.125.047678

Vancouver

Jaffar M, Ahmed K, Abu-Rumeileh S, Otto M, Barba L, Nguyen TN, et al. Role of Thrombectomy Technique in Alteplase Bridging Intravenous Thrombolysis for Basilar Artery Occlusion. Journal of the American Heart Association. 2026. doi:10.1161/jaha.125.047678

BibTeX
@article{Jaffar2026,
  author = {Jaffar, Muhammad and Ahmed, Kazi and Abu-Rumeileh, Samir and Otto, Markus and Barba, Lorenzo and Nguyen, Thanh N and Abdalkader, Mohamad and Klein, Piers and Lobotesis, Kyriakos and Valente, Mariarosaria and Gigli, Gian Luigi and Talukder, Soumik and Prandin, Gabriele and Zhang, Liqun and Foschi, Matteo and Merlino, Giovanni and Simister, Robert and Banerjee, Soma and D'Anna, Lucio},
  title = {Role of Thrombectomy Technique in Alteplase Bridging Intravenous Thrombolysis for Basilar Artery Occlusion},
  journal = {Journal of the American Heart Association},
  year = {2026},
  doi = {10.1161/jaha.125.047678}
}
Kostenlos starten →